Since the first time she treated a child with neuroblastoma, Giselle Saulnier Sholler wanted to do the impossible for her patients. Neuroblastoma is the most common extracranial solid tumor in children with roughly 700 new ...
Jul 12, 2024
0
2
The primary goal in cancer drug research is not merely to discover compounds that can destroy cancer cells, but to develop methods that specifically target and deliver these agents to cancer cells, sparing healthy ones.
Jul 12, 2024
0
0
Scientists at deCODE genetics have published a study in Nature Communications, comparing over 110 thousand patients with autoimmune thyroid disease (AITD) from Iceland, Finland, UK and U.S. with 1.1 million controls. The ...
Jul 12, 2024
0
10
Seventeen women in nine states have fallen ill after getting fake Botox shots, with 13 of them landing in the hospital and one requiring a ventilator, a new report warns.
Jul 12, 2024
0
1
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).
Jul 12, 2024
0
1
A cross-institutional research team led by the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel cinnamaldehyde-based prodrug nanomedicine by utilizing cinnamaldehyde, a common food additive, ...
Jul 12, 2024
0
7
Researchers at The Hospital for Sick Children (SickKids) have found that inflammation in an immune cell may be responsible in part for some severe symptoms in a group of rare genetic conditions called lysosomal storage diseases ...
Jul 12, 2024
0
5
A multicenter safety study at UC Davis Health tested a protein drug (INBRX-101), developed to improve care for people with alpha-1 antitrypsin deficiency (AATD), and showed the therapy is quite safe.
Jul 11, 2024
0
17
While some governments have imposed a tax on unhealthy ingredients in processed foods, others have opted for an outright ban. A recent study led by University of Massachusetts Amherst economists sheds new light on how these ...
Jul 11, 2024
0
15
Three of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows.
Jul 11, 2024
0
0
